Renaissance Technologies’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.6M | Buy |
+245,946
| New | +$10.6M | 0.01% | 1028 |
|
2023
Q4 | – | Sell |
-584,146
| Closed | -$15.4M | – | 3736 |
|
2023
Q3 | $15.4M | Buy |
+584,146
| New | +$15.4M | 0.03% | 689 |
|
2023
Q2 | – | Sell |
-763,746
| Closed | -$12.7M | – | 3910 |
|
2023
Q1 | $12.7M | Sell |
763,746
-266,200
| -26% | -$4.41M | 0.02% | 965 |
|
2022
Q4 | $7.85M | Sell |
1,029,946
-336,800
| -25% | -$2.57M | 0.01% | 1237 |
|
2022
Q3 | $13.6M | Buy |
1,366,746
+953,500
| +231% | +$9.48M | 0.02% | 869 |
|
2022
Q2 | $3.75M | Buy |
+413,246
| New | +$3.75M | ﹤0.01% | 1765 |
|
2021
Q2 | – | Sell |
-118,546
| Closed | -$7.3M | – | 3452 |
|
2021
Q1 | $7.3M | Buy |
+118,546
| New | +$7.3M | 0.01% | 1400 |
|